Palvella Therapeutics (PVLA) Balance Sheet: Assets & Liabilities

Palvella Therapeutics (PVLA) Balance Sheet

As of Mar 31, 2026 (end of fiscal 2025), Palvella Therapeutics reported total assets of $59.56M and total liabilities of $31.58M. Shareholders' equity was $27.98M, down 55.3% from $62.61M a year earlier. Total debt stood at $633.00K against $57.98M in cash and short-term investments, a net cash position of $57.35M. That puts debt-to-equity at 0.02, compared with 0.00 a year earlier.

Palvella Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Palvella Therapeutics, Inc. (PVLA) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	57.98	57.98	83.60	83.60	7.35	16.05	117.76	70.44	62.26	74.87
Short-Term Investments	0.00	-	0.00	-	0.00	0.00	0.00	0.00	41.89	53.24
Cash & Short-Term Investments	57.98	57.98	83.60	83.60	7.35	16.05	117.76	70.44	104.15	128.11
Accounts Receivable	0.00	-	2.34	0.36	0.00	0.00	3.31	1.71	6.79	2.70
Inventory	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.01	1.01	2.30	2.30	0.20	0.47	6.55	3.58	8.14	9.15
Total Current Assets	58.99	58.99	88.23	88.23	7.55	16.52	127.63	75.72	115.01	135.38
Non-Current Assets
Property, Plant & Equipment (Net)	0.57	0.57	0.00	-	0.00	0.00	23.03	25.98	22.94	5.05
Other Non-Current Assets	0.00	-	0.00	-	0.00	0.00	2.90	3.31	3.15	0.91
Total Non-Current Assets	0.57	0.57	0.00	-	0.00	0.00	25.94	29.29	26.08	5.96
Total Assets	59.56	59.56	88.23	88.23	7.55	16.52	153.56	105.01	141.10	141.34
Current Liabilities
Accounts Payable	4.60	4.60	4.59	4.59	0.94	3.18	8.61	1.79	5.80	3.35
Short-Term Debt	0.20	-	0.00	-	0.00	0.00	1.05	1.03	0.73	0.00
Accrued Liabilities	-	4.35	-	5.47	1.42	1.68	16.84	-	-	-
Deferred Revenue	0.00	-	0.00	-	0.00	0.00	25.12	12.63	11.26	35.61
Other Current Liabilities	6.55	2.20	7.45	1.98	1.42	2.60	15.79	6.70	8.69	8.74
Total Current Liabilities	11.34	11.34	12.04	12.04	2.36	5.78	50.56	22.15	27.00	48.08
Non-Current Liabilities
Long-Term Debt	0.43	0.43	0.00	11.94	0.00	0.00	13.84	15.93	15.48	0.00
Deferred Tax Liabilities	0.00	-	0.00	-	0.00	0.00	0.00	0.00	-47.26	0.00
Other Non-Current Liabilities	19.80	19.80	13.59	13.59	9.07	33.92	38.40	0.01	0.00	0.03
Total Non-Current Liabilities	20.23	20.23	13.59	13.59	9.07	33.92	52.24	51.84	62.74	53.33
Total Liabilities	31.58	31.58	25.63	25.63	11.43	39.70	102.81	73.98	89.75	101.41
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00	0.00	0.07	0.06	0.06	0.05
Retained Earnings	-135.45	-135.45	-93.74	-93.74	-76.30	-94.99	-257.14	-211.41	-174.18	-147.07
Accumulated Other Comprehensive Income	0.08	0.08	0.00	0.00	0.00	0.00	0.83	-0.30	-2.00	-2.98
Additional Paid-in Capital	163.34	163.34	156.33	156.33	1.82	1.22	307.00	242.67	227.47	189.93
Shares Outstanding	-	12.38	-	11.01	11.01	11.22	-	-	-	-
Total Stockholders' Equity	27.98	27.98	62.61	62.61	-3.88	-23.17	50.76	31.03	51.35	39.94
Total Liabilities & Equity	59.56	59.56	88.23	88.23	7.55	16.52	153.56	105.01	141.10	141.34

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Palvella Therapeutics Balance Sheet

How much debt does Palvella Therapeutics have?

Palvella Therapeutics had total debt of $633.00K as of Mar 31, 2026, against $57.98M in cash and short-term investments. Its debt-to-equity ratio was 0.02. Total debt was $0.00 a year earlier.

What are Palvella Therapeutics's total assets?

Palvella Therapeutics reported total assets of $59.56M as of Mar 31, 2026, down 32.5% from $88.23M a year earlier. Total liabilities were $31.58M.

What is Palvella Therapeutics's shareholders' equity?

Palvella Therapeutics's shareholders' equity was $27.98M as of Mar 31, 2026.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition